Kathryn Goozee

Kathryn Goozee is an Honorary Associate Professor at Macquarie University's Macquarie Medical School Dementia Research Centre. She holds a PhD in Alzheimer's Disease from the University of Western Australia (2022), focusing on preclinical blood biomarkers and curcumin-based prevention. As CEO/Director of the KaRa Institute of Neurological Diseases since 2015, she leads research into neurological disorders.

Her research focuses on Alzheimer's disease biomarkers, amyloid pathology, and neurodegenerative mechanisms. Key projects include investigating CocoMCT's clinical impacts and hyperspectral retinal imaging for preclinical Alzheimer's diagnosis. She has authored over 29 publications, with an h-index of 20 and 1851 citations.

Her work emphasizes plasma biomarkers for early disease detection and integrates metabolomics, neuroimaging, and clinical trials. Collaborations span international teams, and her research has been featured in journals like Alzheimer's and Dementia and Translational Psychiatry.